Cumulative HIV Viremia during Highly Active Antiretroviral Therapy Is a Strong Predictorof AIDS‐Related Lymphoma
The Journal of Infectious Diseases2009Vol. 200(1), pp. 79–87
Citations Over TimeTop 10% of 2009 papers
Alexander Zoufaly, Hans‐Jürgen Stellbrink, Matthias an der Heiden, Christian Kollan, Christian Hoffmann, Jan van Lunzen, Osamah Hamouda, ClinSurv Study Group
Abstract
Cumulative HIV viremia is an independent and strong predictor of AIDS-related lymphoma among patients receiving HAART. The influence of cumulative HIV viremia may differ between lymphoma subtypes.
Related Papers
- → Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption(2022)32 cited
- Intermittent low-level viremia in very early primary HIV-1 infection.(2005)
- → Viremic Responses of Genetically Susceptible and Resistant Chickens to Experimental Infection with Acute, Mild, or Both Strains of Marek's Disease Herpesvirus(1975)9 cited
- → Studies of Turkey Herpesvirus Viremia in Two Strains of Vaccinated Chickens: Strain Difference and Effects of Vaccine Dose(1977)12 cited